Akums Drugs and Pharmaceuticals Limited IPO

Akums Drugs and Pharmaceuticals Limited is listed in the MAINBOARD segment with a price band of ₹646 to ₹679. The figures below are as reported by the exchanges and public sources.

Akums Drugs and Pharmaceuticals Limited IPO — key facts

• The Akums Drugs and Pharmaceuticals Limited IPO price band is ₹646 to ₹679 per share.
• As of 6 September 2026, the Akums Drugs and Pharmaceuticals Limited IPO subscription status is 63.44x overall.
• The issue is open from 30-JUL-2024 to 01-AUG-2024.
• Akums Drugs and Pharmaceuticals Limited listed on 06-AUG-2024.
• Akums Drugs and Pharmaceuticals Limited listed at ₹796.35. The listing gain was 17.3% against the upper end of the issue price band.

Akums Drugs and Pharmaceuticals Limited IPO details

Status

Listed

Segment

MAINBOARD

Sector

Pharmaceuticals

Price band

₹646 – ₹679

Issue size

₹1856.74 Cr

Fresh issue

₹680.99 Cr

Offer for sale

₹1175.75 Cr

Opens

30-JUL-2024

Closes

01-AUG-2024

Listing

06-AUG-2024

Total subscription

63.44x

Retail

20.80x

QIB

90.09x

NII

42.10x

Lead managers

ICICI Securities (left lead)

Listing price

₹796.35

Listing day change

+17.3%

Other Pharmaceuticals IPOs

• Symbiotec Pharmalab Limited +10.9% on listing
• ABH Healthcare Limited -7.8% on listing
• Bio Medica Laboratories Limited -16.7% on listing
• Goldline Pharmaceutical Ltd. +32.0% on listing
• Sai Parenteral's Limited +3.7% on listing
• Speciality Medicines Ltd. +1.5% on listing

Live subscription, allotment status, offer documents and the full lifecycle timeline for this issue are on this page. Historical listing performance for every past IPO is in the IPO database, and each day's activity is recorded in the daily digest.

Published by INVESTOLOGY — SEBI Registered Research Analyst INH000015297. Data is reported for information only. It is not research and not investment advice. Investments in securities markets are subject to market risk; read all offer documents carefully before investing.